MedPath

Betamethasone Dipropionate

BETAMETHASONE DIPROPIONATE OINTMENT USP, 0.05% (potency expressed as betamethasone) For Dermatologic Use Only – Not for Ophthalmic Use Rx Only

Approved
Approval ID

389cdebb-55fe-4808-a5b7-0f293d9ee45d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 14, 2010

Manufacturers
FDA

Rebel Distributors Corp.

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Betamethasone Dipropionate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-614
Application NumberANDA071012
Product Classification
M
Marketing Category
C73584
G
Generic Name
Betamethasone Dipropionate
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 30, 2009
FDA Product Classification

INGREDIENTS (3)

PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
Betamethasone DipropionateActive
Quantity: 0.05 mg in 1 g
Code: 826Y60901U
Classification: ACTIB
mineral oilInactive
Code: T5L8T28FGP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Betamethasone Dipropionate - FDA Drug Approval Details